These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2391787)

  • 1. Characterization of asialo GM1 positive splenic lymphocytes in Mongolian gerbils.
    Yukawa M; Nishizumi K; Takeuchi T; Mochizuki K; Onodera T
    Nihon Juigaku Zasshi; 1990 Aug; 52(4):861-4. PubMed ID: 2391787
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid.
    Harris MT; Schwarting GA; Stout RD
    Thymus; 1981 Sep; 3(3):169-84. PubMed ID: 6171919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
    Suttles J; Schwarting GA; Stout RD
    J Immunol; 1986 Mar; 136(5):1586-91. PubMed ID: 2936802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective expression of asialo GM1 on maturational subsets of lymphocytes in normal and athymic mice.
    Harris MT; Schwarting GA; Stout RD
    Thymus; 1981 Sep; 3(3):153-67. PubMed ID: 6171918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of monoclonal antibodies against a glycolipid asialo GM1.
    Shimada S; Iwata D
    Microbiol Immunol; 1987; 31(9):923-33. PubMed ID: 3696009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of splenic lymphocytes with high electrophoretic mobility in adult and aged nude mice.
    Shimizu M; Matsuzawa A; Iwaguchi T
    J Immunol Methods; 1985 Nov; 84(1-2):95-103. PubMed ID: 2866215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
    Solomon FR; Higgins TJ
    Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology and function of ganglio-N-tetraosylceramide-positive lymphocyte mediators of natural killer activity.
    Shimamura K; Habu S; Fukui H; Akatsuka A; Okumura K; Tamaoki N
    J Natl Cancer Inst; 1982 Mar; 68(3):449-55. PubMed ID: 6950172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cytotoxic asialo-GM1-positive cells exert antimetastatic activity.
    Strzadala L; Rak I; Ziolo E; Paprocka M; Radzikowski C; Den Otter W
    Cancer Immunol Immunother; 1989; 30(1):51-6. PubMed ID: 2598176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of growth of bovine leukemia cell line (FLK) by anti-asialo GM1 serum and the effect of the serum on NK and K cell activities in nude mice.
    Kodama H; Onuma M; Yamamoto S; Mikami T; Izawa H; Matsumoto K; Naiki M
    Nihon Juigaku Zasshi; 1983 Aug; 45(4):477-85. PubMed ID: 6314024
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of acute graft-versus-host disease-related mortality and cytotoxic T lymphocyte induction after pretreatment of the recipient with anti-asialo GM1 antibody in the murine P-to-F1 model.
    Varkila K; Hurme M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2690-1. PubMed ID: 3274580
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of functional subpopulations of murine natural killer cells based on their cell surface asialo GM1 phenotype.
    Tang J; DeLong DC; Marder P; Butler LD; Ades EW
    Cell Immunol; 1985 Dec; 96(2):386-97. PubMed ID: 3915718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
    Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C; Dennert G
    J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
    Keller R; Bächi T; Okumura K
    Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
    Santoni A; Santoni G; Piccoli M; Herberman RB; Frati L
    Immunopharmacol Immunotoxicol; 1990; 12(3):363-87. PubMed ID: 2148342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytes.
    Merluzzi VJ
    Cell Immunol; 1985 Oct; 95(1):95-104. PubMed ID: 3875426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of NK activity in mouse spleen and peripheral blood lymphocytes.
    Yron I; Erlich R; Efrati M; Shohat L; Witz IP; Sahar E
    Immunobiology; 1988 Sep; 177(4-5):449-59. PubMed ID: 3198147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.